Rockefeller Capital Management L.P. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.

Quarter-by-quarter ownership
Rockefeller Capital Management L.P. ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$12,888,348
-34.9%
126,531
-35.7%
0.05%
-35.1%
Q2 2023$19,811,435
+111538.9%
196,827
+2.0%
0.08%
+1.3%
Q1 2023$17,746
-8.4%
192,909
-9.7%
0.08%
-21.6%
Q4 2022$19,375
-99.9%
213,585
-0.1%
0.10%
+15.5%
Q3 2022$16,251,000
-10.3%
213,828
-0.2%
0.08%
-12.5%
Q2 2022$18,117,000
+2.6%
214,353
+6.5%
0.10%
+12.9%
Q1 2022$17,661,000
-9.7%
201,279
-10.0%
0.08%
-6.6%
Q4 2021$19,552,000
+13.8%
223,545
+6.4%
0.09%
+1.1%
Q3 2021$17,176,000
-6.3%
210,040
+4.6%
0.09%
-12.6%
Q2 2021$18,325,000
+60.8%
200,866
+50.7%
0.10%
+33.8%
Q1 2021$11,394,000
+15.9%
133,313
+28.0%
0.08%
+4.1%
Q4 2020$9,831,000
-25.3%
104,127
-31.2%
0.07%
-39.8%
Q3 2020$13,163,000
-83.1%
151,391
-83.0%
0.12%
-84.9%
Q2 2020$77,898,000
-19.2%
891,905
-23.7%
0.82%
-35.6%
Q1 2020$96,397,000
-17.9%
1,169,160
-5.7%
1.26%
-13.5%
Q4 2019$117,354,000
+7.3%
1,239,353
-1.5%
1.46%
-1.3%
Q3 2019$109,326,000
-4.1%
1,258,076
+0.7%
1.48%
-6.7%
Q2 2019$114,041,000
-5.9%
1,248,943
-1.0%
1.59%
-8.0%
Q1 2019$121,239,000
+12.9%
1,261,069
+0.8%
1.73%
-8.2%
Q4 2018$107,385,000
+2.8%
1,251,429
+3.2%
1.88%
+18.7%
Q3 2018$104,441,000
+39.7%
1,212,185
+22.4%
1.58%
+30.1%
Q2 2018$74,787,000
-7.8%
990,044
-1.3%
1.22%
-9.1%
Q1 2018$81,099,0001,003,0791.34%
Other shareholders
NOVARTIS A G shareholders Q4 2020
NameSharesValueWeighting ↓
NEXTHERA CAPITAL LP 198,000$14,422,0008.45%
PRENTISS SMITH & CO INC 133,202$9,702,0005.92%
EXENCIAL WEALTH ADVISORS, LLC 178,313$12,988,0005.50%
MANAGED ASSET PORTFOLIOS, LLC 185,868$13,538,0005.33%
Osher Van de Voorde Investment Management 114,735$8,357,0004.59%
BROWN BROTHERS HARRIMAN & CO 10,971,272$799,147,0004.37%
PROFESSIONAL ADVISORY SERVICES INC 238,542$17,375,0004.04%
Elefante Mark B 4,579$333,0004.02%
COMPASS CAPITAL MANAGEMENT, INC 271,536$19,779,0003.69%
CGOV Asset Management 972,731$95,135,0003.51%
View complete list of NOVARTIS A G shareholders